|
Adverse effect of androgen deprivation therapy on metabolic syndrome and its components in metastatic prostate carcinoma patients. International Journal of Clinical And Diagnostic Research Volume 7, Issue 6, Nov-Dec 2019.
Cystatin C: A novel marker for early renal impairment in diabetic patients. Scholars Journal of Applied Medical Sciences (SJAMS); Apr 2017; 5(4B):1359-1364.
Long term effects of various therapies on the metabolic risk factors in prostate carcinoma patients. Scholars Journal of Applied Medical Sciences (SJAMS); Mar 2017;5(3B):787-795.
Usefulness of Cystatin C as an index of renal function in diabetic nephropathy. International Journal of Health Sciences and Research. Oct 2015; 10(5):124-128.
Effectiveness of horizontal integrated teaching programme in medical curriculum. Int. Jr. of Pharma Sciences and Research. Jan 2015; 6(6). |